Mitoxantrone plus gemcitabine in pretreated patients with advanced breast cancer.

被引：0
|
作者：
Onyenadum, A [1 ]
Kosmidis, P [1 ]
Aravantinos, G [1 ]
Bafaloukos, D [1 ]
Gogas, H [1 ]
Bacoyiannis, C [1 ]
Razis, E [1 ]
Markopoulos, C [1 ]
Makatsoris, T [1 ]
Kalofonos, HP [1 ]
机构：
[1] Hellen Cooperat Oncol Grp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
829
引用
收藏
页码：83S / 83S
页数：1
相关论文
共 50 条
  • [41] Gemcitabine plus paclitaxel as first-line chemotherapy for patients with advanced breast cancer
    Delfino, C
    Caccia, G
    Gonzáles, LR
    Mickiewicz, E
    Rodger, J
    Balbiani, L
    Morales, DF
    Comba, AZ
    Brosio, C
    ONCOLOGY, 2004, 66 (01) : 18 - 23
  • [42] Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines
    Vici, Patrizia
    Fabi, Alessandra
    Metro, Giulio
    Sergi, Domenico
    Giannarelli, Diana
    Di Lauro, Luigi
    Bepler, Gerold
    Tomao, Federica
    Cognetti, Francesco
    Conti, Francesca
    Lopez, Massimo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 687 - 693
  • [43] MITOXANTRONE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH ADVANCED BREAST-CANCER
    EHNINGER, G
    WEIBLE, KH
    HEIDEMANN, EG
    WALLER, HD
    CANCER TREATMENT REPORTS, 1984, 68 (10): : 1283 - 1284
  • [44] Combination of paclitaxel with mitoxantrone in patients with advanced breast cancer
    Ginopoulos, PG
    Cardamakis, E
    Koukouras, D
    Alivizatos, V
    Safudi, C
    Rathosis, S
    Kalogeropoulos, K
    Tzingounis, V
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 699 - 699
  • [45] A phase II trial of the combination gemcitabine plus vinorelbine in pretreated and heavily pretreated metastatic breast cancer patients, preliminary data.
    Cacciari, N
    Pinto, C
    Giaquinta, S
    Martoni, A
    ANNALS OF ONCOLOGY, 2000, 11 : 37 - 37
  • [46] Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer
    Boeck, Stefan
    Wilkowski, Ralf
    Bruns, Christiane J.
    Issels, Rolf D.
    Schulz, Christoph
    Moosmann, Nicolas
    Laessig, Dorit
    Haas, Michael
    Golf, Alexander
    Heinemann, Volker
    ONCOLOGY, 2007, 73 (3-4) : 221 - 227
  • [47] A randomized phase III study comparing gemcitabine plus pemetrexed versus gemcitabine in patients with locally advanced and metastatic pancreas cancer.
    Richards, DA
    Kindler, HL
    Oettle, H
    Ramanathan, RK
    Van Laethem, JL
    Peeters, M
    Fuchs, M
    John, W
    Arning, M
    Von Hoff, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 315S - 315S
  • [48] Evaluation of gemcitabine plus carboplatin in pretreated, metastatic breast cancer patients: Final analysis of a phase II trial
    Laessig, D.
    Vehling-Kaiser, U.
    Stemmler, H. J.
    Fasching, P.
    Melchert, F.
    Koelbl, H.
    Stauch, M.
    Scharl, A.
    Morack, G.
    Heinemann, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Oxaliplatin, leucovorin and fluorouracil in pretreated patients with advanced colorectal cancer.
    deGramont, A
    Tournigand, C
    Louvet, C
    Andre, T
    Molitor, JL
    Raymond, E
    Moreau, S
    Vignoud, J
    LeBail, N
    Krulik, M
    REVUE DE MEDECINE INTERNE, 1997, 18 (10): : 769 - 775
  • [50] Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer
    V Lorusso
    E Crucitta
    N Silvestris
    A Catino
    L Caporusso
    A Mazzei
    M Guida
    A Latorre
    D Sambiasi
    C D'Amico
    F Schittulli
    P Calabrese
    M De Lena
    British Journal of Cancer, 2003, 88 : 491 - 495
12345